Therapeutic adhesion to oral oncological treatments and interdisciplinary management;Adhésion thérapeutique aux traitements oncologiques oraux et prise en charge interdisciplinaire

Revue Medicale Suisse

Volumn 7, Issue 296, 2011, Pages 1154-1160

  Achtari Jeanneret, L ^a   Schneider, M P ^b   Troxler, S ^b,c,d   Bugnon, O ^b,c,d   Luthi F ^a,e  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e Centre Hospitalier du Centre Valais   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER THERAPY; DRUG FORMULATION; FOLLOW UP; HUMAN; INTERDISCIPLINARY RESEARCH; NEOPLASM; ONCOLOGY; OUTPATIENT; PATIENT COMPLIANCE; PHARMACIST; PILOT STUDY; SHORT SURVEY; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

EID: 84861746995     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (12)

1. www.who.int. World Health Organization. Adherence to long-term therapies. Evidence for action. Report of World Health Organization, 2003 (consulté le 31.3.2011).
2. Liu G, Franssen E, Fitch MI, et al. Patient preferences for oral versus intravenous palliative chemotherapy. JCO 1997:15:110-5. (Pubitemid 27021524)
3. Pfeiffer P, Mortensen JP, Bjerregaard B, et al. Patient preference for oral or intravenous chemotherapy : A randomised cross-over trial comparing capecitabine and Nordic fluorouracil/leucovorin in patients with colorectal cancer. Eur J Cancer 2006;42:2738-43. (Pubitemid 44596255)
4. Vrijens B, Urquhart J. Patient adherence to prescribed antimicrobial drug dosing regimens. J Antimicrob Chemother 2005;55:616-27. (Pubitemid 40691838)
5. Ruddy K, Mayer E, Partridge A. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin 2009;59:56-66.
6. Lebovits AH, Strain JJ, Schleifer SJ. Patient noncompliance with self-administered chemotherapy. Cancer 1990;65:17-22. (Pubitemid 20026803)
7. Waterhouse DM, Calzone KA, Mele C. Adherence to oral tamoxifen : A comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol 1993;11:1189-97. (Pubitemid 23163362)
8. Barron TI, Connolly R, Bennett K. Early discontinuation of tamoxifen : A lesson for oncologists. Cancer 2007;109:832-9. (Pubitemid 46333524)
9. Partridge AH, LaFoutain A, Mayer E. Adherence to initial adjuvant anastrozole therapy among women with early stage breast cancer. J Clin Oncol 2008;26:556-62. (Pubitemid 351264348)
10. Krummenacher I, Cavassini M, Bugnon O, et al. An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoring. Aids Care 2011;23:1-12.
11. Krummenacher I, Cavassini M, Bugnon O, et al. Antiretroviral adherence program in HIV patients : A feasibility study in the Swiss HIV Cohort Study. Pharm World Sci 2010;32:776-86.
12. Cutler DM, Everett W. Thinking outside the pillbox - Medication adherence as a priority for health care reform. N Engl J Med 2010;362:1553-5.